Concepedia

Author

Philippe Collery

Institut Galien Paris-SaclayORCID

Also Known As

Collery, P., D Harding, P Collery, P. Collery, PHILIPPE COLLERY, Philippe COLLERY, Philippe Collery

54

Publications

1.4K

Citations

19

H-Index

49

Concepts

All Affiliations

Institut Galien Paris-SaclayCentre Hospitalier Universitaire de ReimsCentre National de la Recherche ScientifiqueUniversité de Reims Champagne-ArdenneUniversité Paris-Saclay
PC

About

Philippe Collery is an author at Institut Galien Paris-Saclay specializing in medicine, pharmacology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

303

2

Natural Sciences

3

3

108

3

Biochemistry

3

3

108

4

Health Sciences

2

2

32

5

Engineering

1

1

13

Philippe Collery

×

24

Publications

844

Citations

16

H-Index

YearCitations

Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||

Felix Kratz, Ulrich Beyer, Thomas Roth,

Journal of Pharmaceutical Sciences

1998

152

Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer

Philippe Collery, Ahmed Mohsen, Anthony Kermagoret,

Investigational New Drugs

2015

60

Beneficial effects of a vanadium complex with cysteine, administered at low doses on benzo(alpha)pyrene-induced leiomyosarcomas in Wistar rats.

Roman Liasko, T A Kabanos, S. Karkabounas,

PubMed

1998

56

Synthesis, characterization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin

Alexander V. Shtemenko, Philippe Collery, Konstantin V. Domasevitch,

Dalton Transactions

2009

54

Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III).

Philippe Collery, José L. Domingo, Bernhard K. Keppler

PubMed

1996

52

Relationship between magnesium, cancer and carcinogenic or anticancer metals.

J Durlach, M Bara, A Guiet-Bara,

PubMed

1987

47

Inhibitory effects of gallium chloride and tris (8-quinolinolato) gallium III on A549 human malignant cell line.

Philippe Collery, Francoise Lechenault, Annie Cazabat,

PubMed

2000

45

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

Philippe Collery, V. Veena, Adhikesavan Harikrishnan,

Investigational New Drugs

2019

39

Dichlorotetra-mu-Isobutyratodirhenium(III): enhancement of cisplatin action and RBC-stabilizing properties.

Philippe Collery, Alexander V. Shtemenko

PubMed

2007

33

Preparation, Characterization and in Vitro Efficacy of Albumin Conjugates of Doxorubicin.

Felix Kratz, Ulrich Beyer, Philippe Collery,

Biological and Pharmaceutical Bulletin

1998

32

Page 1